APSRX
Price
$15.06
Change
+$0.28 (+1.89%)
Updated
Apr 2 closing price
Net Assets
349.85M
FSMAX
Price
$78.74
Change
-$5.91 (-6.98%)
Updated
Apr 3 closing price
Net Assets
36.55B
Ad is loading...

APSRX vs FSMAX

Header iconAPSRX vs FSMAX Comparison
Open Charts APSRX vs FSMAXBanner chart's image
NYLI Fiera SMID Growth
Price$15.06
Change+$0.28 (+1.89%)
VolumeN/A
Net Assets349.85M
Fidelity Extended Market Index
Price$78.74
Change-$5.91 (-6.98%)
VolumeN/A
Net Assets36.55B
APSRX vs FSMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
APSRX vs. FSMAX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APSRX is a Buy and FSMAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 36.5B vs. APSRX (350M). FSMAX pays higher dividends than APSRX: FSMAX (0.53) vs APSRX (0.00). APSRX was incepted earlier than FSMAX: APSRX (7 years) vs FSMAX (14 years). APSRX (1.23) is less costly to investors than FSMAX (0.04). APSRX is a more actively managed with annual turnover of: 51.00 vs. FSMAX (9.00). FSMAX has a lower initial minimum investment than APSRX: FSMAX (0) vs APSRX (15000). FSMAX annual gain was more profitable for investors over the last year : 3.80 vs. APSRX (-12.03). FSMAX return over 5 years is better than : 106.28 vs. APSRX (27.41).
APSRXFSMAXAPSRX / FSMAX
Total Expense Ratio1.150.043,286%
Annual Report Gross Expense Ratio1.230.043,514%
Fund Existence7 years14 years-
Gain YTD-9.003-6.855131%
Front Load6%N/A-
Min. Initial Investment150000-
Min. Initial Investment IRAN/AN/A-
Net Assets350M36.5B1%
Annual Yield % from dividends0.000.53-
Returns for 1 year-12.033.80-317%
Returns for 3 years-21.978.54-257%
Returns for 5 years27.41106.2826%
Returns for 10 yearsN/A57.10-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MUEVX35.080.24
+0.69%
MFS Blended Research Core Equity R6
JHLVX49.94N/A
N/A
JHancock Fundamental Large Cap Core C
GEMOX11.53N/A
N/A
Goldman Sachs Emerging Mkt Eq ex. ChnInv
BUFSX13.45N/A
N/A
Buffalo Small Cap Growth
AEMOX28.00N/A
N/A
Virtus EM Opps R6